IRADIMED CORP — Director's Dealing 2019

Nov 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2019-11-08

Reporting Person: JOHNSON BRENT (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-08	Common Stock	A	6000	$0.93	Acquired	7368	Direct
2019-11-08	Common Stock	S	6000	$23.06	Disposed	1368	Direct
2019-11-11	Common Stock	A	6000	$0.93	Acquired	7368	Direct
2019-11-11	Common Stock	S	6000	$23.02	Disposed	1368	Direct
2019-11-12	Common Stock	A	11300	$0.93	Acquired	12668	Direct
2019-11-12	Common Stock	S	11300	$23.98	Disposed	1368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-08	Stock Option (Right to Buy)	$0.93	M	6000	Disposed	2021-12-27	Common Stock (6000)	Direct
2019-11-11	Stock Option (Right to Buy)	$0.93	M	6000	Disposed	2021-12-27	Common Stock (6000)	Direct
2019-11-12	Stock Option (Right to Buy)	$0.93	M	11300	Disposed	2021-12-27	Common Stock (11300)	Direct

Footnotes

F1: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2: This transaction was executed in multiple trades at prices ranging from $22.81 to $23.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $23.00 to $23.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $23.60 to $24.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.